HS/CN oznaka 30021098 je izvan područja primjene za EUDR pripremu.
Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins) Indeksirani motor za provjeru područja primjene za ovu oznaku vraća Out of scope. No Annex I scope match was found for this indexed CN code.
Zašto ova referentna stranica daje takav odgovor.
- Opis oznake
- Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
- Osnova iz Priloga I
- Nema izravnog unosa u Prilogu I
- Izvorna osnova
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Nadređeni, podređeni i susjedni redci.
Prikaz knjižnice služi za referentnu navigaciju. Upotrijebite provjeru kada želite pokrenuti drugu oznaku kao radnju.
30farmaceutski proizvodiout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021010antisera(2012-2016);antisera(2002-2011);antisera(1988-2001)out30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Što to znači za pripremu.
Ovaj redak nije izravan pokretač prikupljanja dokaza u trenutnom rezultatu područja primjene.
Regulation (EU) 2023/1115 Annex I — relevant productspreuzeto 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115preuzeto 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)preuzeto 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)preuzeto 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8preuzeto 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingpreuzeto 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and traderspreuzeto 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)preuzeto 2026-08-08